|Year : 2021 | Volume
| Issue : 3 | Page : 261-266
Physiologic testicular uptake of 18-F fluorodeoxyglucose in the Indian population
Girish Kumar Parida1, Gopal Sonai Muthu1, Akchata Suman2, Abhishek Kumar1, Sujata Mitra1
1 Department of Nuclear Medicine and PET-CT, Tata Main Hospital, Jamshedpur, Jharkhand, India
2 Department of Nuclear Medicine and PET-CT, Meherbai Tata Memorial Hospital, Jamshedpur, Jharkhand, India
|Date of Submission||08-Jan-2021|
|Date of Decision||10-Feb-2021|
|Date of Acceptance||24-Feb-2021|
|Date of Web Publication||23-Sep-2021|
Dr. Abhishek Kumar
Tata Main Hospital, Jamshedpur - 831 001, Jharkhand
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objective: The objective of the study is to assess the physiologic uptake of testes in patients undergoing 18F-fluoro-2-deoxyglucose (FDG) position emission tomography/computed tomography (PET/CT) scans for various malignancies other than testicular malignancy. Materials and Methods: The testicular uptake of 18F-FDG expressed as the standardized uptake value (T) was measured on PET/CT images in 320 men with no known testicular pathology from July 2019 to March 2020 at Tata Main Hospital, Jamshedpur. The ratio of maximum standardized uptake value (SUVmax) of the testis (T) to SUVmax of muscle (M) T/M ratio and to SUVmax of the liver (L) T/L ratio was calculated using SUVmax of right adductor muscle and liver, respectively. Testicular volume was calculated with the measurements taken from the axial, coronal, and sagittal slices of CT images. The correlation of testicular uptake with age, blood serum glucose level, and testicular volume was also analyzed. Results: The mean age of 320 men was 57 ± 15 years (range: 10–94) and the mean blood glucose level was 107.7 ± 23.5 mg/dl (range: 64–175). Mean testicular SUVmax in 320 men was 2.48 ± 0.80 (range: 0.67–5.5). The mean testicular volume of 640 testes of 320 men was 18.80 ± 4.83 cm3 (range: 3.85–33.56 cm3). The mean values of (T/M) and (T/L) ratios in the studied population were 3.64 ± 1.21 (range: 1.08–5.58) and 0.97 ± 0.251 (range: 0.34–1.88), respectively. The laterality index (L − R/(L + R) ×2) in 320 men was 0.074 ± 0.050 (0.000–0.308). There was a minimal negative correlation between testicular SUVmax and age (r = −0.136, P = 0.15). Mild negative correlation was noted between T/M ratio and age (r = −0.291, P < 0.0001) and between T/L ratio and age (r = −0.182, P = 0.001) in the studied population. Conclusion: The physiological testicular FDG uptake (SUVmax) of testes was 2.48 ± 0.80 (0.67–5.5) among the Indian population in this study, which has a mild negative correlation with age.
Keywords: 18F-fluoro-2-deoxyglucose position emission tomography/computed tomography, testicular uptake, testicular volume
|How to cite this article:|
Parida GK, Muthu GS, Suman A, Kumar A, Mitra S. Physiologic testicular uptake of 18-F fluorodeoxyglucose in the Indian population. Indian J Nucl Med 2021;36:261-6
|How to cite this URL:|
Parida GK, Muthu GS, Suman A, Kumar A, Mitra S. Physiologic testicular uptake of 18-F fluorodeoxyglucose in the Indian population. Indian J Nucl Med [serial online] 2021 [cited 2022 Aug 16];36:261-6. Available from: https://www.ijnm.in/text.asp?2021/36/3/261/326551
| Introduction|| |
18F-fluoro-2-deoxyglucose (FDG) position emission tomography/computed tomography (PET/CT) is routinely used for the evaluation of patients with different malignancies. Although FDG generally accumulates in malignant lesions in accordance with the Warburg effect, it can also accumulate in normal tissues.,,, The organs that show physiologically increased FDG uptake, include the brain, heart, and genitourinary tracts, such as kidneys and bladder. Other organs, such as the liver, spleen, and gastrointestinal tract, show mild to moderate physiologic uptake.,, The testes typically show mild to moderate physiologic FDG uptake on FDG PET scans, making it challenging to distinguish between the physiological and pathological FDG uptake.,, Hence, an understanding of the normal physiological variations in the distribution of FDG in testes is important for the proper interpretation of FDG-PET/CT scans.,, There are few studies that have already evaluated the physiological FDG uptake in testes; however, no studies are there among the Indian population to the best of our knowledge. In this study, we have retrospectively analyzed the physiological FDG uptake in the apparently healthy testes, among the Indian population, who have undergone FDG PET/CT scans for various malignancies (excluding testicular malignancies).
| Materials and Methods|| |
A total of 340 consecutive men who underwent diagnostic FDG-PET/CT scans at Tata Main Hospital between July 2019 and March 2020 were analyzed in this study. Of these 340 patients, 20 with either history of testicular pathology or unilateral or bilateral orchiectomy [Figure 1] were excluded from the study. The remaining 320 men comprised the study population with no history of any testicular pathology, no abnormal findings in testis on the images of PET/CT, and in their clinical records. All the pretreated patients included in this study have a gap of at least 3 weeks postchemotherapy and 6 weeks postradiotherapy before the PET/CT study. This is our usual institutional protocol. Of the 320 men, 84 were referred for the evaluation of lymphoma, 64 for head-and-neck cancer, 57 for GI malignancy, 41 for lung cancer, 11 for renal cell carcinoma, 10 for myeloma, 10 for sarcoma, and 43 for other cancers.
|Figure 1: For testicular volume estimation length, width and height are measured (a and b) and maximum standardized uptake value is assessed of the testis, adductor magnus muscle, and liver (c and d)|
Click here to view
18F- fluoro-2-deoxyglucose position emission tomography/computed tomography acquisition
Whole-body 18F-FDG PET/CT scanning was performed using a Siemens Biograph Horizon PET/CT scanner (Make: Siemens Medical Solutions USA Inc., Model: Biograph Horizon, Serial number: 94562). All patients had a fasting blood glucose level below 180 mg/dL and received an intravenous injection of 18F-FDG. The average injected dose was 4.3 MBq/kg body weight (range: 2.3–7.1 MBq/kg), and the average time between FDG administration and the start of the PET acquisition was 64 min (range: 43–76 min). A low-dose CT scan was performed in all patients for localization and attenuation correction purposes. Scanning parameters included 50 reference mAs and 130 kV with CARE Dose 4D (Siemens Healthcare Pvt. Ltd., USA). For PET scanning, a three-dimensional emission scan was acquired with 8–10-bedded position, using 2 min/bed position.
Parameters calculated from the position emission tomography/computed tomography images
Images were interpreted on syngo.via VJ20b equipped workstations, using the MM Oncology software package (Siemens Healthcare, Germany), which can display CT, PET, and fused PET/CT images simultaneously. In this retrospective study, following parameters for each patient were recorded in Microsoft Excel sheet: name, age, fasting blood glucose, and creatinine levels. In addition, the following parameters were noted down from the PET/CT images of each patient on the syngo.via work station: maximum standardized uptake value (SUVmax) of each testis separately [Figure 1]c, SUVmax of muscle (M) from the right adductor muscle [Figure 1]c, SUVmax of the liver (L) [Figure 1]d, long-axis diameters of testis were obtained from axial [Figure 1]a, and coronal [Figure 1]b views of the CT image. Mean testicular SUVmax (T) was calculated as the average of right and left testicular SUVmax values. The ratio between testicular uptake and muscle uptake (T/M) and the ratio between testicular uptake and liver uptake (T/L) were calculated. The volume of each testis was then calculated using Lambert's formula: width × length × height × 0.71. The bilateral testicular volumes were then averaged to provide a mean testicular volume for each patient. “Laterality Index” was by calculated using the formula (L − R/(L + R) ×2), where L = left testicular SUVmax and R = right testicular SUVmax for each patient.
All the continuous variables are represented as mean + SD correlation between age and the parameters such as testicular uptake (T), testicular to muscle uptake ratio (T/M), testicular to liver uptake ratio (T/L), plasma glucose levels, and testicular volume in all 320 men were analyzed using Pearson's correlation coefficient test that is available in the XLSTAT 2020 software of the Microsoft Excel. P < 0.05 was considered to be statistically significant.
| Results|| |
Mean testicular SUVmax and volume in 320 men are 2.48 ± 0.80 (range: 0.67–5.5) and 18.80 ± 4.83 cm3 (range: 3.85–33.56 cm3), respectively. The mean values of (T/M) and (T/L) ratios in the studied population were 3.64 ± 1.21 (range: 1.08–5.58) and 0.97 ± 0.251 (range: 0.34–1.88), respectively. The laterality index (L − R/(L + R) ×2) in 320 men was 0.074 ± 0.050 (0.000–0.308). Testicular SUVmax (T), testicular to muscular SUVmax ratio (T/M), testicular to liver SUVmax ratio (T/L), and mean testicular volume in the different age groups are shown in [Table 1]. Correlation of age with testicular SUVmax, T/M ratio, T/L ratio, and testicular volume is shown in [Table 2].
|Table 1: Testicular maximum standardized uptake value (T), testicle to muscle maximum standardized uptake value ratio (T/M), and testicle to liver maximum standardized uptake value ratio (T/L) and mean testicular volume in different age group|
Click here to view
|Table 2: Correlation of age between mean testicular maximum standardized uptake value, T/M ratio, T/L ratio, mean testicular volume, and fasting blood glucose|
Click here to view
Testicular maximum standardized uptake value (T) and age
There were no appreciable differences in the values of testicular SUVmax in the groups of patients up to the age of 70 years; however, there was a fall in SUVmax in the group of patients with age more than 70 years [Table 1]. There was a minimal negative correlation between testicular SUVmax and age (r = −0.136, P = 0.15) [Figure 2]. However, there was a positive correlation when the analysis was performed only on 23 patients with age < 30 years, which was statistically insignificant (r = 0.293, P = 0.175). There was a mild negative correlation when the analysis was done only on the remaining 227 patients with age more than 30 years, which was statistically significant (r = −0.280, P ≤ 0.001).
|Figure 2: Correlation between age and testicular maximum standardized uptake value showing mild negative correlation with r = −136 and P = 0.015|
Click here to view
Testicle to muscle uptake ratio (T/M) and age
T/M ratio showed an increase in value in the age group of <40 years and showed a fall in the value in the age group with age more than 40 years [Table 1]. There was a mild negative correlation between T/M ratio and age in the studied population that was statistically significant (r = −0.291, P < 0.0001) [Figure 3].
|Figure 3: Correlation between age and testis to muscle SUV (T/M) ratio showing moderate negative correlation with r = −0.291 and P ≤ 0.0001|
Click here to view
Testicle to liver uptake ratio (T/L) and age
T/L ratio also showed an increase in value in the age group of <40 years and showed fall in the value in the age group with age more than 40 years [Table 1]. There was a mild negative correlation between T/L ratio and age in the studied population, which was statistically significant (r = −0.182, P = 0.001) [Figure 4].
|Figure 4: Correlation between age and testis to liver SUV (T/L) ratio showing mild negative correlation with r = −0.182 and P = 0.001|
Click here to view
Testicular volume and age
Testicular volume showed an increase in value in the age group of <30 years and showed a fall in the value in the age group with age more than 30 years [Table 1]. There was a moderate positive correlation when the analysis was done only on the patients with age <30 years (r = 0.448, P = 0.0004). However, there was no significant correlation found when the analysis was done on the patients with age more than 30 years (r = −0.039 P ≤ 0.0001).
Testicular standardized uptake value and blood glucose level
The mean blood glucose level before FDG injection in the 320 men was 107.7 + 23.5 mg/dl (64–175). None of these patients received an insulin injection before the scan. There was a statistically insignificant weak negative correlation between blood glucose level and testicular SUVmax (r = −0.049, P = 0.387).
Testicular standardized uptake value and testicular volume
There was a weak positive correlation between the mean testicular SUVmax and volume of bilateral testes in the studied population (r = −0.094, P ≤ 0.0001) that was statistically significant.
| Discussion|| |
In addition to the accumulation of FDG in malignant lesions, physiological FDG uptake has also been seen in some normal tissues on PET scan. It is therefore of utmost importance to differentiate the normal physiological variant from the pathological FDG uptake. Among other organs that show physiological FDG uptake, the testis is not much studied. The physiologic testicular uptake of FDG has been analyzed in a few studies. The mean testicular SUV observed in our study done on the Indian population was 2.48 ± 0.80 [Table 1], which is comparable with the values reported in a study by Kitajima et al. that showed a mean testicular SUV of 2.44 ± 0.45 done on 203 patients. Varying levels of testicular uptake have been reported in various age groups in different studies.,,,,, Our study showed a testicular SUV of 2.52 ± 0.67 in the age group of 10–20 years [Table 1]. Goethals et al. reported a mean testicular SUV of 0.6 ± 0.3 in a study done on 22 patients in the age group of 9–17 years, which is much lower than the SUV observed in our study. This might be due to a high number of prepubertal boys in the study population of Goethals et al. However, there was only one patient with the age of 10 years who showed a mean testicular SUV of 0.82 in our study. Testicular SUV observed in our study on 13 patients in the age group of 21–30 years was 2.53 ± 0.40 [Table 1]. Meij-de Vries et al. reported SUV of 3.42 ± 0.61 in a study done on 20 patients the age group of 18–32 years, that is slightly higher than the SUV observed in our study, probably due to geographical variation. Testicular SUV values observed on 208 patients in the age groups of 41–50, 51–60, and 61–70 years in our study were 2.62 ± 0.0.67, 2.52 ± 0.0.67, and 2.52 ± 1.34, respectively [Table 1]. Moon et al. reported a mean testicular SUV of 1.85 ± 0.33 in a study done on 66 patients in the age group of 37–72 years. Our study has shown slightly higher testicular SUV in this age group of 41–70 years. The variation in testicular SUV among different studies could be due to different instrumentation also, as with time more and more advanced technologies are being used for SUV calculation. However, there is a gradual decrease in the uptake values with increasing age as shown in [Table 1]. Few hypotheses have been put forth to explain this reduction in FDG uptake with increasing age. Some researchers documented that with increasing age, factors such as testicular perfusion and metabolism reduce. As age increases, the germ cell begins to degenerate, and the number and function of the Sertoli and Leydig cells decrease, causing an overall decrease in testicular volume., Thus, our finding that testicular FDG uptake decreased mildly with age after the age of 30 years can also be explained by these physiologic phenomena.
Various formulae have been used to calculate the testicular volume measured from ultrasonography. The formula introduced by Lambert (L × W × H × 0.71) in 1951 has been used in many studies including the one done on the Indian population and is found to be more accurate than other methods.,,, Therefore, we have also used this formula [Figure 2]a and [Figure 2]b. The mean testicular volume observed from CT images in our study was 18.80 ± 4.83 cm3 (3.85–33.56). The mean testicular volume reported by Kitajima et al. was 22.1 ± 6.4 cm3 (3.8–41.5) and by Meij-de Vries was 23.0 ± 6.4 cm3 (10.2–42.8). Mean testicular volume reported by Gupta et al., Huang et al., Fui MNT et al., and Anafa et al. was 16.73 cm3, 16.57 cm3, 18.0 cm3, and 18.57 cm3, respectively. These values observed in studies done in Asia and Australia are similar to the values observed in the Indian population of our study. Higher values observed in other studies may be due to factors such as the regional variation in size of the testes, measurement method, and formula used.
The laterality index calculated with testicular SUV in our study showed a mean value of 0.074 ± 0.050 (0–0.308) with 99% values below 0.204. Laterality index above this range could be a pathological process; however, it will require further evaluation. Laterality index observed in our study was comparable with the values quoted in two other studies with 0.066 ± 0.067 by Kitajima et al. and with 0.077 ± 0.066 by Meij-de Vries et al.
In the correlation analysis between the age and testicular SUV, our study showed a mild negative correlation (r = −0.136, P = 0.015). This is comparable with the correlation values reported by Kitajima et al. (r = −0.284, P < 0.001) and by Moon et al. (r = −0.509, P ≤ 0.001). However, we have also observed a positive correlation (r = 0.293, P = 0.1575) on 23 patients with age <30 years that was not statistically significant and a negative correlation (r = −0.280, P = 0.001) on 297 patients with age >31 years. This is comparable to the values observed by Moon et al. with a positive correlation (r = +0.718 and P = 0.005) in the patients below 25 years of age and a negative correlation (r = −0.240, P ≤ 0.05) in patient above 25 years of age. Meij-de Vries et al. reported a positive correlation (r = 0.349, P < 0.0001) in a study done 20 males with mean of 26.5 ± 3.9 years. Our study shows a mild positive correlation up to the age of 30 years and a mild negative correlation after the age of 31 years while comparing the age and testicular FDG uptake.
When correlating the age with mean testicular volume, we have observed a positive correlation (r = +0.448, P = 0.0004) on 23 patients with age <30 years and a weak negative correlation that is statistically significant (r = −0.039, P ≤ 0.0001) on 297 patients on with age >31 years. Kitajima et al. reported a negative correlation (r = −0.269, P = 0.0001) in the study done on 203 patients with age more than 30 years. Goethals et al. reported a positive correlation (r = +0.670, P ≤ 0.001) in the study done on 22 patients in the age group of 9–17 years. This shows that testicular volume grows for up to approximately 30 years of age, after which no significant change occurs.
Correlation between testicular SUVmax and testicular volume in our study showed a weak positive correlation (r = +0.094, P ≤ 0.001) that was statistically insignificant. Kitajima et al. reported a positive correlation (r = +0.368 and P ≤ 0.001) that was statistically significant.
Correlation between testicular SUV and fasting blood glucose in our study showed a negative correlation (r = −0.049, P = 0.387) that was statically insignificant. Kitajima et al. also reported a negative correlation (r = −0.065 and P = 0.358).
Correlation between age and (T/M) ratio in our study showed a mild negative correlation (r = −0.291, P ≤ 0.0001). This is comparable with the results in a study by Han et al.
We also tried to find if any correlation between age and (T/L) ratio in our study, which showed a mild negative correlation (r = −0.182, P = 0.001).
With such physiological FDG uptake in the testes and variation with age, the nuclear medicine physician needs to rule out physiological uptake before reporting any uptake as pathological. It could also be possible to have a cutoff value for these ratios if done on patients with testicular pathology, which may be useful in differentiating the various types of testicular pathologies. Testicular FDG uptake in various malignant and nonmalignant tumors has been reported in various studies.,,,,,,, More studies and clinical trials are required and would help formulate uniform guidelines for the management of various testicular diseases.
The following are the limitations of the present study: (i) it is a retrospective study, (ii) the age distribution of the participants was uneven, (iii) most participants were in the age groups between 41 and 80 years, and the number of participants in other age groups was relatively small. Around one-fourth of the study patients were having lymphoma. Although we have excluded patients with any apparent testicular abnormality, this could be another limitation of this study.
| Conclusion|| |
In healthy Indian males, the mean SUVmax of the testis was 2.48 ± 0.80 on FDG PET/CT scan. The degree of testicular FDG uptake, testicular to muscle SUV (T/M) ratio, and testicular to liver SUV (T/L) ratio decreases with the increase in age with a mild negative correlation suggesting their limited significance in PET/CT reporting.
The authors are grateful to the General Manager of Medical Services for the support provided to carry out this study at Tata Main Hospital.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006;238:405-22.
Engel H, Steinert H, Buck A, Berthold T, Rahel A, von Schulthess GK. Whole-body PET: Physiological and artefactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441-6.
Strauss LG. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnosis of oncological patients. Eur J Nucl Med 1996;23:1409-15.
Metser U, Even-Sapir E. Increased (18) F-fluorodeoxyglucose uptake in benign, non-physiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): Accumulated data from four years of experience with PET/CT. Semin Nucl Med 2007;37:206-22.
Wang X, Koch S. Positron emission tomography/computed tomography potential pitfalls and artifacts. Curr Probl Diagn Radiol 2009;38:156-69.
Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK, Whole-body PE. Physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37:441-6.
Strauss LG. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-15.
Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Herna Ndez S. Whole-body PET/CT: Spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 2005;26:671-87.
Well D, Yang H, Houseni M, Iruvuri S, Alzeair S, Sansovini M, et al
. Age-related structural and metabolic changes in the pelvic reproductive end organs. Semin Nucl Med 2007;37:173-84.
Reinking MF, Osman MM. Prospective evaluation of physiologic uptake detected with true whole-body 18F-FDG PET/CT in healthy subjects. J Nucl Med Tech 2009;37:31-7.
Kosuda S, Fisher S, Kison PV, Wahl RL, Grossman HB. Uptake of 2-deoxy-2-[18F] fluoro-D-glucose in the normal testis: Retrospective PET study and animal experiment. Ann Nucl Med 1997;11:195-9.
Kim H, Harper L, Habermann TM, Nowakowski GS, Thompson CA, Johnston P, et al
. Clinical significance of testicular FDG-PET/CT uptake in aggressive lymphomas. Blood 2018;132 Suppl 1:5401.
Sidhu P, Lin P, Son H, Rosenfeld D, Lin M. Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: Clinical significance and management impact. Br J Radiol 2014;87:20140472.
Shao D, Gao Q, Tian XW, Wang SY, Liang CH, Wang SX. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT. Eur J Radiol 2017;93:114-20.
Kitajima K, Nakamoto Y, Senda M, Onishi Y, Okizuka H, Sugimura K. Normal uptake of 18F-FDG in the testis: An assessment by PET/CT. Ann Nucl Med 2007;21:405-10.
Meij-de Vries A, Knol R, Lazarenko S, Meijer R, van der Plas E, et al
. Uptake of18F-fluoro-2-deoxyglucose in the Healthy Testes of Young Men as Assessed by Positron Emission Tomography/Computed Tomography; Including the Inter-and Intra-observer Variation. World J Nucl Med 2014;13:88.
Goethals I, De Vriendt C, Hoste P, Smeets P, Ham H. Normal uptake of F-18 FDG in the testis as assessed by PET/CT in a paediatric study population. Ann Nucl Med 2009;23:817-20.
Moon SH, Eo JS, Lee JJ, Chung JK, Lee DS, Lee MC. 18F-FDG uptake of human testis on PET/CT: Correlation with age, sex hormones, and vasectomy. Nucl Med Mol Imaging 2011;45:291-8.
Han EJ, Lee SH, Sohn HS, Chung YA, Chung SK. Assessment of testicular uptake in flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Int J Imaging Syst Technol 2012;22:245-9.
Plas E, Bergerb P, Hermannb M, Pfluger H. Effects of aging on male fertility? Exp Gerontol 2000;35:543-51.
Pasqualotto FF, Sobreiro BP, Hallak J, Pasqualotto EB, Lucon AM. Sperm concentration and normal sperm morphology decrease and follicle-stimulating hormone level increases with age. BJU Int 2005;96:1087-91.
Hsieh ML, Huang ST, Huang HC, Chen Y, Hsu YC. The reliability of ultrasonographic measurements for testicular volume assessment: Comparison of three common formulas with true testicular volume. Asian J Androl 2009;11:261-5.
Gupta S, Samaddar D, Pal D. Objective measurement of testicular volume in Eastern Indian population using ultrasonography and comparison with orchidometer estimates. Scholars J Appl Med Sci 2017;5:4414-9.
Bahk JY, Jung JH, Jin LM, Min SK. Cut-off value of testes volume in young adults and correlation among testes volume, body mass index, hormonal level, and seminal profiles. Urology 2010;75:1318-23.
Huang YP, Liu W, Liu YD, Wang HX, Hu K, Chen B, et al
. Right testicular volume is a dominant predictor of testicular function determined by sperm parameters and total testosterone. Andrologia. 2018;e12955.
Tang Fui MN, Hoermann R, Wittert G, Grossmann M. Testicular volume and clinical correlates of hypothalamic-pituitary-testicular function: A cross-sectional study in obese men. Asian J Androl. 2020 Jul-Aug;22(4):354-359.
Arafa M, Henkel R, Agarwal A, Majzoub A, Elbardisi H. Correlation of oxidation-reduction potential with hormones, semen parameters and testicular volume. Andrologia 2019;51:e13258.
Chopra S, Dharmaraja A, Mehta P, Colletti PM, Wassef H. FDG PET/CT images demonstrating epididymo-orchitis in a patient with HIV, acute kidney injury and known epididymo-orchitis on scrotal ultrasound. Clin Nucl Med 2015;40:e171-2.
Yang J, Zhu S, Pang F, Xu M, Dong Y, Hao J, Ma X. Functional parameters of 18F-FDG PET/CT in patients with primary testicular diffuse large B-cell lymphoma. Contrast Media Mol Imaging 2018;2018:1-7.
Kassem TW. Do we need 18F-FDG PET/CT scan in staging and management of testicular tumors? Egypt J Radiol Nucl Med 2016;47:445-52.
Shammas A, Lim R, Charron M. Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions. Radiographics 2009;29:1467-86.
Tripathy S, Mukherjee A, Bal C, Tripathi M, Mallick S, Shamim SA. Primary germ cell tumor of testes with extensive lymph nodal and splenic metastases masquerading lymphoma n 18-F-FDG PET/CT. Ind J Nucl Med 2017;32:153-4.
Yin Y, Qing F, Li X, Du B, Li N, Li Y. Non-Hodgkin's lymphoma of the testicle and bilateral adrenals detected by 18F-FDG PET/CT. Exp Ther Med 2011;2:817-20.
Kuo PH, Cooper DL, Cheng DW. Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT. Semin Nucl Med 2006;36:105-7.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2]